|
RxNorm
|
Resource Development
|
FDA
|
NLM
|
RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software. By providing links between these vocabularies, RxNorm can mediate messages between systems not using the same software and vocabulary.
|
|
Sabbatical in Clinical Research Management Program
|
Training Initiative
|
FDA, OS
|
CC, FIC, NCATS, NEI, NHLBI, NIAID, NIDCR, NIDDK, NLM
|
Experienced investigators come to the National Institutes of Health (NIH) to learn about management of a clinical research enterprise, including topics such as planning and budget development, protocol writing and tracking and scientific review. Sabbaticals are self-directed, meaning that the participant chooses from a list of electives and helps determine how much time to spend studying each topic. The electives are offered by leaders at the NIH and other U.S. Department of Health and Human Services agencies with the NIH Clinical Center being the most heavily involved.
|
|
Safe to Sleep Breastfeeding Outreach Meeting
|
Meeting/ Workshop
|
ACF, CDC, HRSA, OS
|
NICHD
|
The purpose of this meeting was to gain knowledge from key stakeholders from national breastfeeding organizations on the best ways to develop safe infant sleep messages, which promote breastfeeding to breastfeeding educators and breastfeeding mothers.
This meeting brought together groups representing different points of view to lay a foundation for future discussions. These discussions focused on how we can share common messages as we work together to educate the public about the safe infant sleep. The agreements reached in these sessions will help chart future steps for the successful NICHD Safe to Sleep campaign.
|
|
Safety and Efficacy Evaluations of Topical Microbicide (TM) Biomedical Prevention (BP) Products in the Repeat Low-Dose Macaque SIV/SHIV Infection Model
|
Research Initiative
|
CDC
|
NIAID
|
The National Institute of Allergy and Infectious Diseases (NIAID) and Centers for Disease Control and Prevention (CDC) recognize the need to perform preclinical safety and efficacy evaluations of candidate products in the repeat low-dose (RLD) macaque SIV/SHIV infection model that has been established by CDC. NIAID established an interagency agreement with CDC to: 1) conduct safety and efficacy evaluations of Topical Microbicide/Biomedical Prevention products in the RLD macaque model, including pharmacokinetic/pharmacodynamic analyses of candidate biomedical prevention products; 2) utilize relevant macaque species, virus strains, and routes of infection to accomplish the proposed evaluations; and 3) perform other macaque studies as needed.
|
|
Safety Reporting Portal
|
Resource Development
|
FDA
|
OD/OSP
|
Development of a portal to streamline the process of reporting pre- and post-market safety data to the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) and to serve as a prototype for a federal-wide system. The Portal is an important policy innovation and major step forward in the effort to eliminate unnecessary complexities and inefficiencies associated with the current system of reporting adverse events. The Portal uses a harmonized set of terms, the Basal Adverse Event Report, to provide a single, web-based interface for standardized electronic reporting of adverse events and unanticipated problems to NIH and FDA and also enables the transmission of reports to local oversight bodies such as institutional review boards (IRBs) and data and safety monitoring boards (DSMBs).
|
|
SAMHSA Recovery Month
|
Public Education Campaign
|
SAMHSA
|
NIDA
|
The Substance Abuse and Mental Health Services Administration (SAMHSA) annual public health observance for people in recovery from substance abuse; The National Institute on Drug Abuse (NIDA) is part of SAMHSA''s inter-agency planning committee and a promotional partner.
|
|
SEARCH for Diabetes in Youth
|
Research Initiative
|
CDC
|
NIDDK
|
SEARCH is a multi-center study that identifies cases of diabetes in children/youth, providing data on incidence and prevalence in the U.S. as well as data on diabetes management and complications.
|
|
Second National CFAR/APC/DOH ECHPP Working Group Meeting
|
Meeting/ Workshop
|
CDC
|
NIAID, NICHD, NIDA, NIMH
|
The January 2014 meeting provided a forum for networking and collaboration for CFAR-, D.C. Department of Health (DOH)-, and NIMH-supported AIDS Prevention Center (APC) investigators, as well as a platform for the presentation of progress and results of the NIH supported HIV Continuum of Care research projects.
|
|
Sequencing Quality Control (SEQC) Toxicogenomics (TGMX) Study
|
Research Initiative
|
FDA
|
NIEHS
|
To compare TGMX results between microarray and RNA-seq.
|
|
Sleep Disorders Research Advisory Board
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NHLBI, NCATS, NCCAM, NCI, NIA, NICHD, NIDA, NIDDK, NINDS, NINR, OD/DPCPSI/OBSSR, OD/DPCPSI/ORWH
|
The Advisory Board shall advise, assist, consult with, and make recommendations to the Director of the National Institutes of Health, through the Director of the Institute, and the Director of the Center concerning matters relating to the scientific activities carried out by and through the Center and the policies respecting such activities, including recommendations. (42 USC § 285b–7)
|